Stakeholders Battle Over Feasibility Of Retroactive Ruling in King

December 23, 2014 at 5:07 PM
With oral arguments in the King v. Burwell lawsuit now set for early March, some policymakers and advisers are still fiercely debating whether the U.S. Supreme Court could rule that the federally facilitated marketplace's premium tax credits are retroactively illegal and require subsidy recipients to reimburse the cost of those credits. Health law supporters say that there is no possibility that the IRS would require repayments, while opponents are saying that Americans should be warned of the potential. Asked...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.